SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950103-24-001047
Filing Date
2024-01-24
Accepted
2024-01-24 08:00:36
Documents
13
Period of Report
2024-01-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dp205528_8k.htm   iXBRL 8-K 26548
2 EXHIBIT 10.1 dp205528_ex1001.htm EX-10.1 38772
  Complete submission text file 0000950103-24-001047.txt   247609

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE adct-20240118.xsd EX-101.SCH 3036
4 XBRL LABEL FILE adct-20240118_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE adct-20240118_pre.xml EX-101.PRE 22373
7 EXTRACTED XBRL INSTANCE DOCUMENT dp205528_8k_htm.xml XML 3397
Mailing Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066
Business Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066 41 21 653 02 00
ADC Therapeutics SA (Filer) CIK: 0001771910 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39071 | Film No.: 24554279
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)